<DOC>
	<DOCNO>NCT02432248</DOCNO>
	<brief_summary>The purpose study investigate effect DHEA treatment subfertile patient poor ovarian reserve post-treatment evaluation IVF outcome .</brief_summary>
	<brief_title>Effect DHEA Patients With Poor Ovarian Responds</brief_title>
	<detailed_description>The aim randomize control study compare effect DHEA placebo live birth rate poor ovarian responder . Consecutive infertile woman attend subfertility clinic IVF treatment approach . Those fulfil selection criterion would recruit write consent obtain detailed explanation counseling . Baseline assessment perform early follicular phase ( Day 2 3 ) recruitment . Patient characteristic include age , body mass index ( BMI ) , smoke status would record blood test include follicular stimulate hormone ( FSH ) , estradiol ( E2 ) , testosterone anti-Müllerian hormone ( AMH ) would check . Pelvic scan perform assess total antral follicle count ( AFC ) total ovarian volume . Subjects randomize divide two group : 1 . DHEA group : Subjects take DHEA ( Vitacost ) 25mg three time day 12 week prior start IVF treatment . 2 . Placebo group : Subjects take placebo three time day 12 week prior start IVF treatment . Ultrasound assessment repeat follicular phase ( D2 3 ) every month cycle follow IVF treatment use antagonist protocol base standard departmental regimen . Cycle characteristic include dose gonadotrophin use , duration stimulation , number oocyte obtain , number fertilize embryos good quality embryo record follicular fluid save hormonal profile .</detailed_description>
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Dehydroepiandrosterone</mesh_term>
	<criteria>Indicated IVF treatment accord standard department protocol Age &lt; 42 Regular menstrual cycle ( 2135 day ) Poor ovarian responder define accord Bologna criterion fulfil 2 3 following : Advanced maternal age ( ≥40 ) genetic acquire risk factor POR Previous poor ovarian response ( POR ) ( ≤3 oocytes conventional stimulation protocol use least 150IU gonadotrophin per day ) Abnormal ovarian reserve test ( i.e . AFC &lt; 57 AMH &lt; 0.51.1ng/ml ) . Alternatively , two episode POR maximal stimulation sufficient define patient poor responder absence advance maternal age abnormal ORT . Previous chemotherapy pelvic irradiation Polycystic ovarian syndrome polycystic ovary On hormonal supplementation indication time recruitment ( e.g . estrogen , testosterone DHEA )</criteria>
	<gender>Female</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>42 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>DHEA</keyword>
	<keyword>live birth rate</keyword>
	<keyword>poor ovarian responder</keyword>
</DOC>